Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation

European Heart Journal

Volumn 26, Issue 20, 2005, Pages 2185-2192

  Asaumi, Yasuhide ^a   Yasuda, Satoshi ^a   Morii, Isao ^a   Kakuchi, Hiroyuki ^a   Otsuka, Yoritaka ^a   Kawamura, Atsushi ^a   Sasako, Yoshikado ^a   Nakatani, Takeshi ^a   Nonogi, Hiroshi ^a   Miyazaki, Shunichi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Echocardiography; Extracorporeal circulation; Myocarditis; Shock

Indexed keywords

CREATINE KINASE MB;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MALE; MYOCARDITIS; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; ASSISTED CIRCULATION; CASE-CONTROL STUDIES; CRITICAL ILLNESS; ECHOCARDIOGRAPHY; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 26044446408     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi411     Document Type: Article

References (32)

1. Cooper LT Jr. Myocarditis: from Bench to Bedside. Totowa, New Jersey: Humana Press; 2003.
2. Liu P, Mason J. Advances in the understanding of myocarditis. Circulation 2001;104:1076-1082.
3. Feldmann AM, McNamara D. Myocarditis. N Eng J Med 2000;343:1388-1398.
4. Kato S, Morimoto S, Hiramatsu S, Nomura M, Ito T, Hishida H. Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis. Am J Cardiol 1999;83:623-625.
5. Chen JM, Spanier TB, Gonzalez JJ, Marelli D, Flannery MA, Tector KA, Cullinane S, Oz MC. Improved survival using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant 1999;18:351-357.
6. Acker MA. Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann Thorac Surg 2001;71:S73-S76.
7. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001;122:440-448.
8. McCarthy RE III, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Eng J Med 2000;342:690-695.
9. Swan HJC, Forrester JS, Diamond G, Chatterjee K, Parmley WW. Hemodynamic spectrum of myocardial infarction and cardiogenic shock. Circulation 1972;45:1097-1110.
10. Sasako Y, Nakatani T, Nonogi H, Miyazaki S, Kito Y, Takano H, Kawashima Y. Clinical experience of percutaneous cardiopulmonary support. Artif Organs 1996;20:733-736.
11. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. Recommendation for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
12. Kircher BJ, Himelman RB, Shiller NB. Non invasive estimation of right atrial pressure from the respiratory collapse of the inferior vena cava. Am J Cardiol 1999;66:493-496.
13. Nakatani T, Takano H, Beppu S, Noda H, Taenaka Y, Kumon K, Kito Y, Fujita T, Kawashima Y. Practical assessment of natural heart function using echocardiography in mechanically assisted patients. ASAIO Trans 1991;37: M420-M421.
14. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987;18:619-624.
15. Takano H, Nakatani T. Ventricular assist systems: experience in Japan with Toyobo pump and Zeon pump. Ann Thorac Surg 1996;61:317-322.
16. Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg 2001;71:S77-S81.
17. Magovern GJ, Kathleen A, Simpson KA. Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. Ann Thorac Surg 1999;68:655-661.
18. Pennington DG, Smedira NG, Samuels LE, Acker MA, Curtis JJ, Pagani FD. Mechanical circulatory support for acute heart failure. Ann Thorac Surg 2001;71(Suppl. 3):S56-S59.
19. Sasayama S, Matsumori A, Kihara Y. New insights into the pathophysiological role for cytokines in heart failure. Cardiovasc Res 1999;42:557-564.
20. Mann DL. Inflammatory mediator and failing heart: past, present and foreseeable future. Circ Res 2002;91:988-998.
21. Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newburger JW. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994;89:252-257.
22. McNamara DM, Rosenblum WD, Janosko KM, Trost MK, Villaneuva FS, Demetris AJ, Murali S, Feldman AM. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997;95:2476-2478.
23. Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. Interferon-beta treatment eliminates cardiotropic viruses and improvement left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003;107:2793-2798.
24. Kishimoto C, Takada H, Hiraoka Y, Shinohara H, Kitazawa M. Protection against murine Coxackievirus B3 myocarditis by T cell vaccination. J Mol Cell Cardiol 2000;32:2269-2277.
25. Matsumoto Y, Jee Y, Sugisaki M. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J Immunol 2000;164:2248-2254.
26. Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 2000;36:227-232.
27. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Eng J Med 1995;333:269-275.
28. Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, Edwards WD, Rodeheffer RJ. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995;26:80-84.
29. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991;18:1617-1626.
30. Kodama M, Oda H, Okabe M, Aizawa Y, Izumi T. Early and long-term mortality of the clinical subtypes of myocarditis. Jpn Circ J 2001;65:961-964.
31. D'Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, Di Sciascio G. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001;85:499-504.
32. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Eng J Med 1985;312:885-890.